Our data show that, in contrast to sHDL from HC, sHDL from RRMS patients was not capable to suppress inflammation-induced pro-inflammatory gene expression of tumor necrosis factor alpha (TNFα), CD40, IL1β, and IFNγ in monocytes obtained from healthy controls (Fig. 3). This evidence concerns the gene CD40 and relapsing-remitting multiple sclerosis.